Patent · US Active

Polymeric hGH prodrugs

US12133883B2 · kind B2 · utility

1Cited by
20References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 28, 2020
Grant dateNov 5, 2024
Priority date
Expiry dateAug 13, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC08G2650/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a polymeric human growth hormone prodrug and dry, liquid and reconstituted pharmaceutical formulation comprising said prodrug. It furthermore relates to their use as medicaments for the treatment of diseases which can be treated with growth hormone and to methods of treatment. It also relates to methods of application of such polymeric human growth hormone prodrug or pharmaceutical formulation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.